https://www.selleckchem.com/pr....oducts/bay-11-7082-b
ccuracy were 98.57%, 81.48%, and 93.81%, respectively. Conclusion The current study using objective parametric tools for both EUS elastography and contrast-enhanced EUS confirmed the results of previous studies and meta-analyses that indicated a complementary role for the differential diagnosis of focal pancreatic masses. Moreover, the best values for the receiver operating curves were obtained using a sequential clinical algorithm based on the initial use of elastography, followed by contrast enhancement.Background and